References
- Hoomans T, van der roer N, Severens JL, et al. Cost-effectiveness of new drugs (in Dutch). Nederlands Tijdschrift voor Geneeskunde 2010;154:A958
- Samama CM, Vray M, Barré J, Fiessinger JN, et al; SACRE Study Investigators. Extended venous thromboprophylaxis after total hip replacement: a comparison of LMWH with oral anticoagulant. Arch Intern Med 2002;162:2191-6
- Eriksson BI, Friedman RJ. Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty. Clin Appl Thromb Hemost 2009;10.1177/1076029609340668
- Tan SS, Bouwmans CA, Rutten FF, et al. Update of the Dutch manual for costing in economic evaluations. Int J Technol Assess Health Care 2012;28:152-8